Chapter 5 130 REFERENCES Alzheimer’s Disease International (2018) From plan to impact Progress towards targets of the Global action plan on dementia. Available at: https://www.alz.co.uk/adi/pdf/from-plan-to-impact-2018.pdf. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (revised 4th ed.). Washington, DC: American Psychiatric Association. American Psychiatric Association (2013) DIAGNOSTIC AND STATISTICAL MENTAL DISORDERS (DSM 5), American Psychiatric Association. Batelaan, N. M. et al. (2007) ‘Thresholds for health and thresholds for illness: Panic disorder versus subthreshold panic disorder’, Psychological Medicine, 37(2), pp. 247–256. doi: 10.1017/ S0033291706009007. Blair, M. et al. (2016) ‘Depressive Symptoms Negatively Impact Montreal Cognitive Assessment Performance: A Memory Clinic Experience’, Canadian Journal of Neurological Sciences. Cambridge University Press, 43(4), pp. 513–517. doi: 10.1017/cjn.2015.399. Borland, E. et al. (2017) ‘The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort’, Journal of Alzheimer’s Disease, 59(3), pp. 893–901. doi: 10.3233/JAD-170203. Borson, S. et al. (2013) ‘Improving dementia care: The role of screening and detection of cognitive impairment’, Alzheimer’s and Dementia. Elsevier Inc., pp. 151–159. doi: 10.1016/j.jalz.2012.08.008. Bossuyt, P. M. et al. (2015) ‘STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies’, Clinical Chemistry, 61(12), pp. 1446–1452. doi: 10.1373/clinchem.2015.246280. Bruijnen, C. J. W. H. et al. (2020) ‘Psychometric properties of the Montreal Cognitive Assessment (MoCA) in healthy participants aged 18–70’, International Journal of Psychiatry in Clinical Practice, 24(3), pp. 293–300. doi: 10.1080/13651501.2020.1746348. Burn, A. M. et al. (2018) ‘Dementia case-finding in hospitals: A qualitative study exploring the views of healthcare professionals in English primary care and secondary care’, BMJ Open. BMJ Publishing Group, 8(3), p. e020521. doi: 10.1136/bmjopen-2017-020521. Canevelli, M. et al. (2016) ‘Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition: A Systematic Review of Literature and Meta-Analysis’, Journal of the American Medical Directors Association, 17(10), pp. 943–948. doi: 10.1016/j.jamda.2016.06.020. Carson, N., Leach, L. andMurphy, K. J. (2018) ‘A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores’, International Journal of Geriatric Psychiatry, 33(2), pp. 379–388. doi: 10.1002/gps.4756. Costa, A. S. et al. (2012) ‘Alternate-form reliability of the montreal cognitive assessment screening test in a clinical setting’, Dementia and Geriatric Cognitive Disorders, 33(6), pp. 379–384. doi: 10.1159/000340006. Dautzenberg, G., Lijmer, J. and Beekman, A. (2020) ‘Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls’, International Journal of Geriatric Psychiatry. John Wiley and Sons Ltd, 35(3), pp. 261–269. doi: 10.1002/gps.5227. Dautzenberg, G., Lijmer, J. and Beekman, A. (2021) ‘Clinical value of the Montreal Cognitive Assessment (MoCA) in patients suspected of cognitive impairment in old age psychiatry. Using the MoCA for triaging to a memory clinic’, Cognitive Neuropsychiatry, 26(1), pp. 1–17. doi: 10.1080/13546805.2020.1850434.
RkJQdWJsaXNoZXIy MTk4NDMw